URN:NBN:SI:doc-FCBHC7362017Marc, Gašperdocuments/doc/F/URN_NBN_SI_doc-FCBHC736_001.pdfdocuments/doc/F/URN_NBN_SI_doc-FCBHC736_001.txt468articlestr. 298-3020014-822930982183URN:NBN:SI:doc-FCBHC736slvSlovensko farmacevtsko društvoFarmacevtski vestnikInCMonoclonal antibodies: What 's next?Monoklonska protitelesa: kako naprej?